TLDR Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.
A 31-year-old woman with relapsing-remitting MS developed alopecia areata (AA) after her second course of alemtuzumab treatment. Despite initial treatment with intralesional corticosteroids, significant hair loss continued. However, following an acute MS relapse treated with intravenous methylprednisolone, she experienced rapid and complete hair regrowth. This case highlighted a potential temporal link between alemtuzumab and AA, suggesting that systemic corticosteroids might be effective for treating alemtuzumab-related AA. Long-term follow-up was recommended to assess hair regrowth and recurrence risk.
99 citations
,
July 2017 in “Clinical Reviews in Allergy & Immunology” New treatments for Alopecia Areata show promise but need to be more effective and affordable.
79 citations
,
December 2013 in “Journal of Investigative Dermatology Symposium Proceedings” Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.
11 citations
,
January 2022 in “Journal der Deutschen Dermatologischen Gesellschaft” Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.
1 citations
,
July 2023 in “Journal of Clinical Medicine” Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.
January 2026 in “Clinical & Translational Oncology” Early intervention and tailored management are crucial for skin side effects in cancer treatments.
3 citations
,
May 2023 in “Journal of the American Academy of Dermatology” Certain drugs can cause hair loss, but stopping the drug usually leads to hair regrowth.
11 citations
,
December 2010 in “American journal of transplantation” Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.
